Task: Answer the multiple choice question.
Query: Which drug exhibits a -66.392% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCC(C)N(CCNC(=O)c1ccc2c(c1)NC(=O)c1ccccc1S2)C1CCCCC1
b) CCc1c(C)[nH]n(-c2nc(-c3cccc([N+](=O)[O-])c3)cs2)c1=O
Answer: a. CCC(C)N(CCNC(=O)c1ccc2c(c1)NC(=O)c1ccccc1S2)C1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)N(CCNC(=O)c1ccc2c(c1)NC(=O)c1ccccc1S2)C1CCCCC1
CCC(C)N(CCNC(=O)c1ccc2c(c1)NC(=O)c1ccccc1S2)C1CCCCC1
N-[2-[butan-2-yl(cyclohexyl)amino]ethyl]-6-oxo-5H-benzo[b][1,4]benzothiazepine-3-carboxamide